tiprankstipranks
Trending News
More News >
Encompass Health (EHC)
:EHC
US Market

Encompass Health (EHC) Ratios

Compare
384 Followers

Encompass Health Ratios

EHC's free cash flow for Q1 2025 was $0.48. For the 2025 fiscal year, EHC's free cash flow was decreased by $ and operating cash flow was $0.19. See a summary of the company’s cash flow.
Ratios
TTM
Dec 24Dec 23Dec 22Dec 21
Liquidity Ratios
Current Ratio
1.05 1.28 1.25 1.23 1.32
Quick Ratio
0.97 1.28 1.19 1.14 1.23
Cash Ratio
0.13 0.11 0.04 0.07 0.31
Solvency Ratio
0.14 0.16 0.14 0.14 0.12
Operating Cash Flow Ratio
0.88 1.30 1.23 0.96 0.98
Short-Term Operating Cash Flow Coverage
7.97 34.31 13.89 8.82 8.48
Net Current Asset Value
$ -3.39B$ -2.96B$ -3.06B$ -3.54B$ -3.50B
Leverage Ratios
Debt-to-Assets Ratio
0.55 0.48 0.53 0.52 0.55
Debt-to-Equity Ratio
2.48 1.78 2.28 1.85 2.23
Debt-to-Capital Ratio
0.71 0.64 0.70 0.65 0.69
Long-Term Debt-to-Capital Ratio
0.66 0.59 0.65 0.63 0.64
Financial Leverage Ratio
4.50 3.70 4.30 3.59 4.06
Debt Service Coverage Ratio
3.32 5.30 3.42 3.01 2.66
Interest Coverage Ratio
4.57 5.10 3.57 5.00 3.59
Debt to Market Cap
0.51 0.36 0.41 0.65 0.46
Interest Debt Per Share
35.78 30.92 31.94 37.40 37.80
Net Debt to EBITDA
3.57 2.79 3.40 3.96 4.07
Profitability Margins
Gross Profit Margin
96.35%19.44%95.35%95.91%95.68%
EBIT Margin
15.04%15.64%14.41%13.07%11.55%
EBITDA Margin
19.79%21.34%20.09%17.16%17.55%
Operating Profit Margin
15.85%15.24%14.44%16.07%14.25%
Pretax Profit Margin
12.21%12.65%10.37%12.83%10.18%
Net Profit Margin
7.79%7.33%6.23%8.05%6.12%
Continuous Operations Profit Margin
9.69%9.89%8.06%7.87%5.99%
Net Income Per EBT
63.79%57.97%60.12%62.72%60.14%
EBT Per EBIT
77.06%82.97%71.79%79.87%71.40%
Return on Assets (ROA)
5.90%5.77%4.81%6.00%4.41%
Return on Equity (ROE)
26.53%21.37%20.68%21.57%17.90%
Return on Capital Employed (ROCE)
13.61%13.44%12.41%13.45%11.55%
Return on Invested Capital (ROIC)
10.57%10.42%9.51%10.42%8.82%
Return on Tangible Assets
10.87%7.75%6.62%10.26%7.69%
Earnings Yield
6.65%5.30%4.57%8.02%4.38%
Efficiency Ratios
Receivables Turnover
9.10 7.85 8.10 10.20 8.11
Payables Turnover
1.77 22.75 1.52 1.56 1.74
Inventory Turnover
2.93 0.00 6.40 3.22 3.07
Fixed Asset Turnover
2.06 1.37 1.38 1.80 1.89
Asset Turnover
0.76 0.79 0.77 0.75 0.72
Working Capital Turnover Ratio
377.46 29.39 27.71 25.36 34.91
Cash Conversion Cycle
-40.76 30.45 -137.90 -84.37 -45.28
Days of Sales Outstanding
40.11 46.50 45.06 35.78 45.02
Days of Inventory Outstanding
124.78 0.00 57.07 113.53 119.06
Days of Payables Outstanding
205.65 16.04 240.02 233.68 209.35
Operating Cycle
164.90 46.50 102.13 149.31 164.07
Cash Flow Ratios
Operating Cash Flow Per Share
6.48 8.55 7.11 7.23 7.15
Free Cash Flow Per Share
2.36 2.69 1.23 1.66 3.01
CapEx Per Share
4.12 5.86 5.89 5.57 4.14
Free Cash Flow to Operating Cash Flow
0.36 0.31 0.17 0.23 0.42
Dividend Paid and CapEx Coverage Ratio
1.24 1.32 1.03 1.08 1.35
Capital Expenditure Coverage Ratio
1.57 1.46 1.21 1.30 1.73
Operating Cash Flow Coverage Ratio
0.19 0.29 0.24 0.20 0.20
Operating Cash Flow to Sales Ratio
0.14 0.18 0.16 0.14 0.15
Free Cash Flow Yield
4.28%4.03%2.05%3.20%4.57%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
15.05 18.86 21.89 12.46 22.81
Price-to-Sales (P/S) Ratio
1.17 1.38 1.36 1.00 1.40
Price-to-Book (P/B) Ratio
3.99 4.03 4.53 2.69 4.08
Price-to-Free Cash Flow (P/FCF) Ratio
23.35 24.80 48.75 31.21 21.86
Price-to-Operating Cash Flow Ratio
8.50 7.80 8.41 7.18 9.20
Price-to-Earnings Growth (PEG) Ratio
0.68 0.63 -0.64 0.28 -1.07
Price-to-Fair Value
3.99 4.03 4.53 2.69 4.08
Enterprise Value Multiple
9.49 9.27 10.19 9.81 12.02
Enterprise Value
8.65B 9.50B 8.90B 8.62B 9.80B
EV to EBITDA
9.49 9.27 10.19 9.81 12.02
EV to Sales
1.88 1.98 2.05 1.68 2.11
EV to Free Cash Flow
37.41 35.50 73.16 52.37 33.06
EV to Operating Cash Flow
13.62 11.17 12.61 12.04 13.91
Tangible Book Value Per Share
-8.66 7.41 3.19 -4.51 -7.59
Shareholders’ Equity Per Share
13.80 16.56 13.21 19.31 16.11
Tax and Other Ratios
Effective Tax Rate
0.21 0.22 0.22 0.21 0.22
Revenue Per Share
46.99 48.25 43.84 51.73 47.10
Net Income Per Share
3.66 3.54 2.73 4.16 2.88
Tax Burden
0.64 0.58 0.60 0.63 0.60
Interest Burden
0.81 0.81 0.72 0.98 0.88
Research & Development to Revenue
0.00 0.00 0.00 0.00 0.00
SG&A to Revenue
0.63 0.04 0.60 0.62 0.63
Stock-Based Compensation to Revenue
0.02 0.01 <0.01 <0.01 <0.01
Income Quality
1.42 2.35 1.93 1.38 1.91
Currency in USD
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis